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Abstract
 
Contact-mediated interactions between CD4
 
 
 
T cells and B cells are considered crucial for T
cell–dependent B cell responses. To investigate the ability of activated CD4
 
 
 
T cells to drive in
vivo B cell responses in the absence of key cognate T–B interactions, we constructed radiation
 
bone marrow chimeras in which CD4
 
 
 
T cells would be activated by wild-type (WT) dendritic
cells, but would interact with B cells that lacked expression of either major histocompatibility
complex class II (MHC II) or CD40. B cell responses were assessed after influenza virus infection
of the respiratory tract, which elicits a vigorous, CD4
 
 
 
T cell–dependent antibody response in
WT mice. The influenza-specific antibody response was strongly reduced in MHC II knockout
and CD40 knockout mice. MHC II–deficient and CD40-deficient B cells in the chimera environ-
ment also produced little virus-specific immunoglobulin (Ig)M and IgG, but generated a strong
virus-specific IgA response with virus-neutralizing activity. The IgA response was entirely
influenza specific, in contrast to the IgG2a response, which had a substantial nonvirus-specific
component. Our study demonstrates a CD4
 
 
 
T cell–dependent, antiviral IgA response that is
generated in the absence of B cell signaling via MHC II or CD40, and is restricted exclusively
to virus-specific B cells.
Key words: B lymphocytes • T lymphocytes • antibody formation • immunoglobulin A • 
mucosal immunity
 
Introduction
 
The standard model for the induction of T-dependent Ab
responses to protein Ags commences with Ag uptake by
professional APCs, such as DCs, which migrate to secondary
lymphoid tissues and present peptide fragments of pro-
cessed Ag on their surface in the context of MHC class II
(MHC II) molecules (1). Specific CD4
 
 
 
T cells are activated
and undergo clonal expansion after TCR recognition of
peptide/MHC II on the APC, and the subsequent binding
of costimulatory molecules, such as CD28, on the T cell
with ligands on the APC (2). Meanwhile, Ag-specific naive
B cells internalize and process Ag bound by surface Ig recep-
tors, leading to surface presentation of antigenic peptides in
the context of MHC II molecules. The T help necessary to
drive the B cell response is delivered by the expanded pop-
ulation of specific CD4
 
 
 
T cells, and is initiated by TCR
engagement of peptide/MHC II on the B cell. Subse-
quently, up-regulated CD40 ligand (CD40L) on the T cell
delivers an essential proliferative signal to the B cell via
CD40, and T cell–derived cytokines drive B cell proliferation
and direct Ig isotype switching (3–6).
In this model, cognate, Ag-specific recognition of B cells
by T helper cells is a requirement for B cell proliferation
and differentiation, but this imposes a significant delay on
humoral responses. The frequencies of Ag-specific T and B
cells are low at the time of initial Ag encounter, and the
expectation is that specific CD4
 
 
 
T cell numbers must be
 
Address correspondence to Mark Y. Sangster, Department of Microbiol-
ogy, M409 Walters Life Sciences Building, University of Tennessee,
Knoxville, TN 37996. Phone: (865) 974-4028; Fax: (865) 974-4007;
email: msangste@utk.edu
 
Abbreviations used in this paper:
 
 AFC, Ab-forming cell; ALP, alkaline phos-
phatase; CD40L, CD40 ligand; GC, germinal center; i.n., intranasal(ly);
MDCK, Madin-Darby canine kidney; MHC II, MHC class II; MLN,
mediastinal LN.
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expanded to generate sufficient cells to permit the likeli-
hood of cognate T–B interactions. This scenario appears
inconsistent with the strong humoral responses that are rap-
idly generated against many pathogens (7–9). It has been
proposed (10) that cognate T–B interactions might be facil-
itated by an early, T cell–independent phase of B cell pro-
liferation and IgM secretion driven by repetitive antigenic
structures.
The rapidity of humoral responses to infection may also
be due in part to the ability of activated T cells to provide
bystander or nonspecific help for B cell responses. Such
help is independent of cognate, Ag-specific T–B interac-
tions, and might be mediated by secreted cytokines or non-
specific molecular interactions between adjacent cells.
There is considerable in vitro evidence that in the presence
of appropriate B cell activation signals, the cytokine prod-
ucts of activated T cells will promote B cell proliferation
and the production of switched Ab isotypes (11). However,
the significance of bystander help in vivo is not known. It
is noteworthy that DCs have been shown to retain Ag in a
form that is recognized by B cells (12) and also provide sig-
nals that direct isotype switching in T-dependent humoral
responses (12, 13). The precise contribution of T cells in
this situation is uncertain (14), and a role for bystander help
by T cells should be considered.
This study was initiated to assess the physiological rele-
vance of bystander help for the B cell response to influenza
virus infection in mice. Radiation BM chimeras were con-
structed in which virus-specific CD4
 
 
 
T cell activation oc-
curred, but cognate, Ag-specific recognition of B cells by
CD4
 
 
 
T cells was prevented by the absence of MHC II ex-
pression on B cells. Thus, CD4
 
 
 
T cell help for B cell re-
sponses could only be delivered through alternative, non-
Ag–specific cognate interactions, or via soluble factors. The
results of this analysis lead us to apply the chimera approach
to determine whether activated CD4
 
 
 
T cells could also
drive virus-specific Ab responses in the absence of signaling
to B cells via CD40. In parallel studies, the radiation BM
chimeras were used to investigate the requirements for
nonvirus-specific Ab induction by influenza virus. Collec-
tively, our findings point to a mechanistic distinction be-
tween the early, influenza-specific IgA response, and the
IgM and IgG responses.
 
Materials and Methods
 
Mice.
 
The C57BL/6J (B6) and C57BL/6J-
 
Igh
 
a 
 
Thy1
 
a 
 
Gpi1
 
a
 
(B6-
 
Igh
 
a
 
) mice, and mice deficient for CD40 (B6.129P2-
 
Tnfrsf5
 
tm1Kik
 
; reference 15) or both the 
 
 
 
and 
 
 
 
T cell receptor
(B6.129P2-
 
Tcrb
 
tm1Mom 
 
Tcrd
 
tm1Mom
 
; reference 16) were purchased
from The Jackson Laboratory. MHC II–deficient (I-A
 
b
 

 
/
 

 
) mice
(17) and B cell–deficient C57BL/6-Igh-6 (
 

 
MT) mice (18) were
bred at Charles River Laboratories.
Radiation BM chimeras in which all B cells were deficient in
the expression of MHC II were generated by i.v. injection of
equal numbers of T cell–depleted I-A
 
b
 

 
/
 
 
 
and 
 

 
MT BM cells
(1–2 
 
	 
 
10
 
7 
 
total injected cells) into 8–10-wk-old B6-
 
Igh
 
a 
 
mice
that had been lethally irradiated (950 rad) 1 d previously. Chimeric
mice in which all B cells were CD40
 

 
/
 
 
 
were generated in the
 
same way, except that CD40
 

 
/
 
 
 
BM was used instead of I-A
 
b
 

 
/
 

 
BM. Control chimeras with WT B cells were made using a com-
bination of B6 and 
 

 
MT donor BM. Two sets of additional con-
trol chimeras were produced by reconstituting B6-
 
Igh
 
a 
 
recipients
with 
 

 
MT BM alone or with a mixture of 
 

 
MT and B6.
 
Igh
 
a
 
BM. Recipient mice were held for at least 10 wk before virus
challenge. During this period, the characteristics of peripheral
blood lymphocytes were verified by flow cytometry (19). Chi-
meric mice were also analyzed by flow cytometry at the time of
sampling. The staining reagents were FITC-conjugated mAbs to
B220 (RA3-6B2), CD4 (RM4-5), CD40 (HM40-3), IgM
 
a 
 
(DS-
1), and IgM
 
b 
 
(AF6-78); PE-conjugated mAbs to B220, CD8
 

 
(53-6.7), CD90.1 (OX-7), CD90.2 (53-2.1), and I-A
 
b 
 
(AF6-
120.1); and APC-conjugated mAbs to B220 and CD3
 

 
 
(145-
2C11; BD Biosciences).
Mice were housed under specific pathogen-free conditions un-
til virus infection and thereafter in BL2-level containment. Fe-
males were used in all studies and, with the exception of the BM
chimeras, were infected at 8–12 wk of age. The Animal Care and
Use Committee of St. Jude Children’s Research Hospital ap-
proved all animal procedures.
 
Infection and Sampling.
 
Mice were anesthetized with Avertin
(2,2,2-tribromoethanol) given i.p., and then infected intranasally
(i.n.) with 10
 
6.8 
 
50% egg infectious doses of the H3N2 influenza A
virus HKx31 (30 
 

 
l in PBS). Anesthetized mice were exsan-
guinated via the retro-orbital plexus before sampling. Nasal cavi-
ties were washed with PBS/0.1% BSA as described by Nedrud et
al. (20). Centricon YM-30 centrifugal filter devices (Millipore)
were used as instructed by the manufacturer to concentrate pooled
nasal washings to 
 

 
5% of the starting volume. Sera and nasal
washings were stored at 
 

 
20
 

 
C for later determination of Ab ti-
ters. The right posterior mediastinal LN (MLN) and spleen were
collected and disrupted to generate single cell suspensions (21).
 
In Vivo CD4
 
 
 
T Cell Depletion.
 
Mice were depleted of
CD4
 
 
 
T cells using the CD4-specific mAb GK1.5 as previously
described (19).
 
ELISPOT Assay for Ab-forming Cells (AFCs).
 
Influenza-spe-
cific AFCs were enumerated by ELISPOT assay. Plates were
coated with purified influenza HKx31 (Charles River Laborato-
ries) and single cell suspensions were plated and incubated as pre-
viously described (21). Replicate plates were developed with an
allotype-specific set and a nonallotype-specific set of detection
Abs. Biotinylated allotype-specific mAbs to IgM
 
a 
 
(DS-1), IgM
 
b
 
(AF6-78), IgG1
 
a 
 
(10.9), IgG1
 
b 
 
(B68-2), IgG2a
 
a 
 
(8.3), and IgG2a
 
b
 
(5.7) purchased from BD Biosciences, and biotinylated anti-IgA
 
a
 
(Hy-16) and anti-IgA
 
b 
 
(HIS-M2) were diluted optimally in PBS
plus 2% FCS and added to the plates. After overnight incubation
at 4
 

 
C, plates were washed and incubated with peroxidase-labeled
goat anti–biotin (Vector Laboratories) at 5 
 

 
g/ml in PBS-Tween
(0.05%)-FCS (1%) for 1–2 h at room temperature. Plates were
washed thoroughly and incubated at room temperature with the
developing substrate 3-amino-9-ethylcarbazole (Sigma-Aldrich)
to allow spot formation. The nonallotype-specific reagents, alka-
line phosphatase (ALP)-conjugated goat anti–mouse Abs with
specificity for IgM, IgA, IgG1, IgG2a, IgG2b, or IgG3 (Southern
Biotechnology Associates, Inc.), were used in combination with
the substrate 5-bromo-4-chloro-3-indolyl phosphate (Sigma-
Aldrich) to generate spots (21). Plates were washed and dried af-
ter optimal spot development, and spots representing individual
AFCs were counted using an Olympus SZH Stereozoom micro-
scope. Comparable results were obtained when AFCs producing
a particular isotype were detected using either the allotype-spe-
cific mAb, or the nonallotype-specific goat anti–mouse Ab. Al-
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though Abs detected using the anti-IgG2a
 
b 
 
mAb or the nonallo-
type-specific anti-IgG2a reagent are referred to as IgG2a, it
should be noted that IgG2a expressed by B6 mice is now recog-
nized as a distinct isotype designated IgG2c (22).
Total AFC numbers were determined using assays specific for
the Igh
 
b 
 
allotype. Plates were coated with mAbs to IgA
 
b 
 
(HIS-
M2) or IgG2a
 
b 
 
(5.7; BD Biosciences), and bound Abs were de-
tected using ALP-conjugated goat anti–mouse IgA or IgG2a
(Southern Biotechnology Associates, Inc.), respectively. Spots
were visualized with the 5-bromo-4-chloro-3-indolyl phosphate
substrate.
 
ELISA for Virus-specific Ab.
 
Influenza-specific Ab levels in
sera and nasal washes were determined by ELISA (21) using plates
coated with 0.5 
 

 
g/well of purified, detergent-disrupted influ-
enza HKx31 (Charles River Laboratories). Bound Ab was de-
tected with ALP-conjugated goat anti–mouse Abs specific for
IgM, IgA, IgG1, IgG2a, IgG2b, or IgG3 (Southern Biotechnol-
ogy Associates, Inc.), followed by 
 
p
 
-nitrophenylphosphate sub-
strate (Sigma-Aldrich). Influenza-specific Ab concentrations in
arbitrary units per milliliter were calculated from standard curves
constructed using HKx31-immune serum (for IgA) or HKx31-
specific mAbs (provided by R. Webster, St. Jude Children’s Re-
search Hospital, Memphis, TN) representing the IgM, IgG1,
IgG2a, IgG2b, and IgG3 isotypes.
 
Virus Neutralization Assay.
 
Madin-Darby canine kidney
(MDCK) cells in MEM (Invitrogen) containing 2 mM 
 
l
 
-gluta-
mine, 100 IU/ml penicillin, 100 
 

 
g/ml streptomycin, 10 
 

 
g/ml
gentamicin, and 5% FCS were grown in flat-bottom 96-well tis-
sue culture plates (Sarstedt). Influenza A virus HKx31 was diluted
in MEM supplemented with 
 
l
 
-glutamine, antibiotics, 1 
 

 
g/ml
TPCK-trypsin (Sigma-Aldrich), and 0.3% BSA to give 4 
 
	 
 
10
 
2
 
50% tissue culture infectious dose/ml, and then mixed with equal
volumes of nasal wash concentrates. After incubation for 2 h at
37
 

 
C in a 5% CO
 
2 
 
atmosphere, the virus/sample mixtures were
added to washed MDCK monolayers in the 96-well plates. Plates
were incubated for 3 d at 37
 

 
C in a 5% CO
 
2 
 
atmosphere, and
wells that were positive for virus growth were identified by hem-
agglutination of chicken RBCs.
 
Assaying Virus-specific CD4
 
 
 
T Cell Activation.
 
Influenza-spe-
cific CD4
 
 
 
T cell frequencies were determined as previously de-
scribed (19). In brief, splenic CD4
 
 
 
T cells were enriched by neg-
ative selection and incubated in vitro with either HKx31-infected
or -uninfected irradiated splenocytes. The frequency of virus-spe-
cific CD4
 
 
 
T cells was calculated from the number of IFN-
 

 
–
producing cells measured by ELISPOT assay after 2–3 d incuba-
tion.
 
Statistics.
 
Statistical comparisons of mean values were per-
formed using the nonparametric Mann-Whitney U test for un-
paired samples.
 
Results
 
The Influenza-specific B Cell Response Is CD4
 
 
 
T Cell De-
pendent.
 
Influenza A virus infection of the respiratory
tract in mice generates a rapid and vigorous humoral re-
sponse in regional LNs, particularly the MLN that drains
the lower respiratory tract (8). Initial experiments charac-
terized the Ab response elicited in the MLN and estab-
lished its T cell dependence.
i.n. infection with influenza virus generated a response in
the MLN characterized by the early appearance of virus-
specific IgM AFCs, followed by increased numbers of cells
 
producing virus-specific IgA and the IgG subclasses (Fig. 1
A). A strong, virus-specific IgA response developed early
and peaked on day 7, whereas the near maximal virus-spe-
cific IgG response on day 7 was sustained for at least 2
more days. The specificity of the AFC responses in the
MLN of influenza-infected mice was demonstrated in par-
allel assays using plates coated with Sendai virus Ags. No
spots representing IgA or IgG AFCs developed on the Sen-
dai-coated plates, and only 
 

 
3% of the IgM AFCs induced
by influenza infection were cross-reactive (not depicted).
Subsequent experiments focused on the influenza-specific
response in the MLN on days 7 and 9 after infection.
The depletion of CD4
 
 
 
T cells resulted in a dramatic re-
duction in the number of cells producing virus-specific Ab
of each isotype (Fig. 1 B), indicating that the humoral re-
sponse in this model is largely dependent on CD4
 
 
 
T cell
help. Essentially identical results were obtained when the B
cell response to influenza infection was compared in I-A
 
b
 

 
/
 

Figure 1. The influenza-specific AFC response in the MLN is CD4 T
cell dependent. A kinetic analysis of the early, influenza-specific AFC
response in the MLN of B6 mice was performed (A). Mice were infected
i.n. with influenza virus and the ELISPOT assay was used to measure
virus-specific AFC frequencies at intervals after infection. The influenza-
specific AFC response in the MLN was then analyzed at selected times
after infection in CD4 T cell–depleted B6 mice and mock-depleted
controls (B), and in  and  T cell receptor–deficient mice (TCR/)
and WT B6 controls (C). Results are expressed as the number of AFCs/105
nucleated cells. The mean  SE is shown for three to nine individual
mice per group.
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mice (CD4 T cell–deficient) and WT controls (unpub-
lished data). The virus-specific Ab response was almost com-
pletely absent in mice lacking all T lymphocytes (Fig. 1 C).
Bystander CD4 T Cell Help Contributes Only to the Virus-
specific IgA Response. Having established the CD4 T cell
dependence of the early B cell response to influenza infec-
tion, the question was whether a component of this essen-
tial T cell help could be delivered in bystander fashion
without classical cognate, Ag-specific recognition of B
cells. To address this question, radiation BM chimeras were
constructed by reconstituting lethally irradiated recipient
mice with a combination of BM from I-Ab/ mice and
MHC II/ B cell–deficient (MT) mice. The chimeric
mice would thus carry MHC II/ B cells and MHC II/
DCs and macrophages necessary for normal CD4 T cell
activation. Effective priming of specific CD4 T cells does
not require MHC II–expressing B cells (23), and can even
be achieved in the complete absence of B cells when influ-
enza virus infection is the stimulus (24). Control WT chi-
meras were constructed using donor BM from B6 mice and
MT mice. Congenic, Ig heavy chain allotype-disparate
WT mice with normal lymphoid tissue microarchitecture
were used as BM recipients so that allotype-specific single
cell assays could be used to distinguish Ig production by
donor-derived (Ighb) and host-derived (Igha) cells.
Influenza infection did not result in a virus-specific Ab
response in the MLNs of MT mice or mice reconstituted
with only MT BM (Fig. 2). In addition, Ighb B cells (po-
tentially of MT origin) did not contribute to the strong
influenza-specific response in the recipients of MT and
B6-Igha BM (Fig. 2). These experiments established that
cells derived from donor MT BM in the chimera system
did not produce Ab in response to infection.
Flow cytometric analysis of chimeric mice before virus
challenge established that circulating B cells were MHC
II/ in chimeras constructed with I-Ab/ plus MT BM,
and MHC II/ in the control chimeras (Fig. 3 A). There
was no evidence of residual recipient Igha B cells in any
chimeric mice (Fig. 3 B), a result supported by phenotyp-
ing of MLN cells at intervals after virus infection (unpub-
lished data). Analysis of MLN cells after infection also es-
tablished that the frequencies of B cells (B220), CD4 T
cells, and CD8 T cells were not significantly different in
the chimeras with MHC II/ B cells compared with the
control chimeras (unpublished data).
Figure 2. Cells derived from MT BM do not produce
Abs in response to influenza infection. Mice were infected
i.n. with influenza virus and sampled after 7 d. Virus-specific
AFC frequencies in the MLN are shown for B cell–deficient
(MT), B6, and B6-Igha mice, and the radiation BM chimeras
MT → B6-Igha and MT plus B6-Igha → B6-Igha. The
numbers of cells in MLN cell suspensions producing virus-
specific IgM, IgG1, IgG2a, IgG2b, IgG3, or IgA were
determined by nonallotype-specific ELISPOT assays. In
parallel, total IgG2ab and IgAb AFC numbers were deter-
mined by ELISPOT assays specific for the Ighb allotype
(the allotype of MT and B6 mice). Results are expressed
as the number of AFCs/105 nucleated cells. The mean 
SE is shown for five individual mice in the mMT group
and the chimera groups. B6 and B6-Igha results are for
pools of two mice.
Figure 3. Flow cytometric analysis of peripheral blood B cells in chi-
meric mice. Peripheral blood lymphocytes were obtained from individual
radiation BM chimeras I-Ab/ plus MT → B6-Igha, CD40/ plus
MT → B6-Igha, and B6 plus MT → B6-Igha, and from B6 and B6-Igha
mice as staining controls. The I-Ab/ plus MT → B6-Igha chimeras
have CD4 T cells, MHC II–deficient B cells of the Ighb allotype (I-Ab/),
and MHC II/ macrophages and DCs (MT). The CD40/ plus
MT → B6-Igha chimeras have CD4 T cells, CD40-deficient B cells of
the Ighb allotype (CD40/), and CD40/ macrophages and DCs
(MT). The B6 plus MT → B6-Igha WT control chimeras have WT
Ighb B cells. Residual recipient WT B cells in the chimeras would be Igha.
Representative staining is shown for gated B cells (B220) analyzed for
the expression of MHC II (A), IgMa (B), or CD40 (C).
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The activation of influenza-specific CD4 T cells in the
spleen on days 7 and 9 after infection was evaluated by
IFN- ELISPOT assay. There were insufficient cells for an
analysis of both B cell and CD4 T cell responses in the
MLN of individual mice. Frequencies of IFN- spot-form-
ing cells per 106 splenic CD4 T cells (mean  SE) were
90  24 (day 7) and 166  51 (day 9) for chimeras with
MHC II/ B cells, and 349  73 (day 7) and 142  65
(day 9) for WT control chimeras. IFN- spot-forming cells
did not develop in parallel control cultures incubated with
mock-infected stimulator cells (unpublished data). This
analysis demonstrates that virus-specific CD4 T cells were
activated in the chimeras with MHC II/ B cells.
Virus-specific B cell responses in the MLN were com-
pared after influenza infection of the chimeric mice, I-Ab/
mice, and B6 mice (Fig. 4). Strong, virus-specific IgM
(day 7) and IgG (days 7 and 9) responses were of similar
magnitude in the control chimeras and B6 mice. In con-
trast, IgM and IgG responses were substantially diminished
in the chimeras with MHC II/ B cells and in I-Ab/
mice, indicating a requirement for cognate T–B collabora-
tion mediated by B cell expression of MHC II. Surpris-
ingly, on both days 7 and 9, a vigorous, virus-specific IgA
response developed in the chimeras with MHC II/ B
cells. This response was significantly elevated compared
with the response in I-Ab/ mice, and not significantly
different from that in B6 mice. Apparently, MHC II/ B
cells can be driven to produce substantial virus-specific IgA
in the presence of activated CD4 T cells. This bystander
help contributed only to the IgA response and had little, if
any, impact on IgM or IgG production by MHC II/ B
cells. Although there was a small but consistent increase in
the IgG2b response in the chimeras with MHC II/ B
cells compared with I-Ab/ mice, the levels remained sub-
stantially lower than in B6 mice. The virus-specific IgA re-
sponse in the MLN on day 7 was also enhanced in the WT
control chimeras compared with B6 mice. The reason for
this is unclear, but might be related to increased T and/or
B cell activation because we noted perivascular lymphoid
Figure 4. MHC II–deficient B cells generate a vigorous, influenza-specific
IgA response in the MLN of chimeric mice. Mice were infected i.n. with
influenza virus and sampled after 7 (A) or 9 d (B). Virus-specific AFC
frequencies are shown for MHC II–deficient mice (I-Ab/), B6 mice,
and the radiation BM chimeras I-Ab/ plus MT → B6-Igha and B6 plus
MT → B6-Igha described in the legend to Fig. 3. Responses were ana-
lyzed using a combination of nonallotype-specific ELISPOT assays and
ELISPOT assays that were specific for the donor (Ighb) allotype in the
BM chimeras. Importantly, ELISPOT assays specific for IgMa, IgG1a,
IgG2aa, or IgAa (the allotype of the recipient B6-Igha mice) were always
applied in analyzing the responses of the BM chimeras and were invariably
negative. Results are expressed as the number of AFCs/105 nucleated
cells. The mean  SE is shown for 9–23 and 7–8 individual mice per
group on days 7 and 9, respectively. B6 compared with I-Ab/: P  0.0001
(day 7) and P  0.005 (day 9) for IgM, IgG1, IgG2a, IgG2b, IgG3, or
IgA. I-Ab/ compared with I-Ab/ plus MT → B6-Igha: P  0.0001
(day 7) and P  0.005 (day 9) for IgA; P  0.05 (days 7 and 9) for IgG2b;
P  0.05 (day 9) for IgM. B6 compared with I-Ab/ plus MT → B6-Igha:
P  0.0001 (day 7) for IgM, IgG1, or IgG3; P  0.0005 (day 7) for
IgG2a or IgG2b. B6 compared with B6 plus MT → B6-Igha: P  0.005
(day 7) for IgA.
Figure 5. Serum levels of influenza-specific IgA are similar in chimeric
mice with MHC II/ B cells and in WT control chimeras. Sera were
collected 9 d after i.n. influenza infection of the radiation BM chimeras
I-Ab/ plus MT → B6-Igha and B6 plus MT → B6-Igha described in
the legend to Fig. 3. Virus-specific serum Ab titers in arbitrary units per
milliliter were determined by ELISA. Titers are shown for individual
mice, and a horizontal bar identifies the mean. *, P  0.005 and #, P  0.05
compared with I-Ab/ plus MT → B6-Igha chimeras.
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accumulations in the lungs of uninfected control chimeras
that were not present in B6 mice or in chimeras with
MHC II/ B cells (unpublished data).
Serum levels of virus-specific Abs in the chimeric mice
on day 9 after infection (Fig. 5) were consistent with the
response profiles measured at the single cell level in the
MLN (Fig. 4).
Bystander CD4 T Cell Help Drives Physiologically Relevant
Virus-specific IgA Production. Influenza infection of the re-
spiratory tract rapidly leads to the appearance of virus-spe-
cific IgA in the nasal passages and airways, where it con-
tributes to virus clearance (25–27). Therefore, we assessed
the physiological significance of virus-specific IgA produc-
tion driven by bystander CD4 T cell help by examining
virus-specific IgA recovered in nasal washings.
A kinetic study was undertaken comparing virus-specific
IgA levels in nasal washings from I-Ab/ mice and B6
mice. In addition, nasal washings were collected on day 9
after infection from chimeras with MHC II/ B cells and
control chimeras. Virus-specific IgA was detected in the
nasal wash of B6 mice as early as day 7 after infection (Fig.
6 A), correlating well with the early induction of IgA AFCs
in the MLN (Fig. 1 A). Nasal wash levels in B6 mice con-
tinued to increase to a plateau by day 14. In contrast, virus-
specific IgA was almost absent in the nasal washes from
I-Ab/ mice, indicating a dependence on CD4 T cells.
The levels of virus-specific IgA in nasal washings from chi-
meras with MHC II/ B cells were significantly higher
than in those from I-Ab/ mice, and not significantly dif-
ferent from the levels in the control chimeras or B6 mice.
Thus, bystander CD4 T cell help was responsible for the
early appearance of virus-specific IgA at a significant site of
influenza virus replication (27, 28).
Importantly, IgA produced by MHC II/ B cells in the
chimera environment displayed virus-neutralizing activity.
Influenza virus growth in vitro was completely blocked by
day 9 nasal wash concentrates from B6 mice, WT control
chimeras, and chimeras with MHC II/ B cells (Fig. 6 B).
In contrast, the day 9 concentrate from I-Ab/ mice was
not neutralizing. Analysis of nasal wash concentrates for in-
fluenza-specific Abs demonstrated that IgA was the only
isotype present at significant levels, and prominent IgA ti-
ters correlated well with the development of virus-neutral-
izing activity (Fig. 6 B). Therefore, we conclude that the
neutralizing activity was a function of IgA.
T Cell Activation Drives Virus-specific IgA Production in the
Absence of CD40 Signaling to B Cells. The delivery of a
proliferative signal to the B cell after CD40–CD40L interac-
tion is considered an essential requirement for T-dependent
humoral responses (5). Having demonstrated the ability of
MHC II/ B cells to mount a vigorous, virus-specific IgA
response in the context of CD4 T cell activation, we next
asked whether CD4 T cell activation could also facilitate vi-
rus-specific Ab production by CD40/ B cells.
Analysis of the influenza-specific AFC response in the
MLN on day 7 after infection demonstrated that the pro-
duction of all Ab isotypes was substantially diminished in
CD40/ mice compared with WT controls (unpublished
data), a result consistent with previous studies of other
T-dependent Ab responses in CD40/ mice (15, 29).
However, CD4 T cell activation by professional APCs is
dependent on CD40–CD40L interactions (30), and the
level of influenza-specific CD4 T cell activation was, as
expected, much reduced in mice deficient in CD40 or
CD40L (unpublished data).
The radiation BM chimera approach previously de-
scribed was therefore modified to allow analysis of the anti-
viral responses of CD40/ B cells in the context of CD4
T cell activation. Lethally irradiated recipient mice were
reconstituted with BM from both CD40/ mice and
MT mice to generate chimeras carrying CD40/ B cells,
and the CD40/ professional APCs necessary for normal
CD4 T cell activation. Flow cytometric analysis of periph-
eral blood lymphocytes before virus challenge (Fig. 3 C)
Figure 6. Analysis of IgA in nasal washings. Mice were infected i.n.
with influenza virus. Nasal washings were collected at intervals from
MHC II–deficient (I-Ab/) mice and B6 mice, and on day 9 after infection
from the radiation BM chimeras I-Ab/ plus MT → B6-Igha and B6
plus MT → B6-Igha described in the legend to Fig. 3. (A) Influenza-specific
IgA levels in nasal washings. Levels of virus-specific IgA in arbitrary units
per milliliter were measured by ELISA. Each point represents the mean
for three to six individual mice. Statistics are only shown for day 9 com-
parisons. *, P  0.01 and #, P  0.05 compared with I-Ab/ mice. (B)
Influenza-neutralizing activity and Ab isotype composition of nasal washings.
Pooled washings from individual mice were concentrated to 5% of the
starting volume. Nasal wash concentrates that completely blocked the
replication of influenza virus in MDCK cells were scored as positive ()
for virus neutralizing activity (neut). Levels of influenza-binding Abs in
the nasal wash concentrates were measured by ELISA and are expressed as
the absorbance of a 1 in 20 dilution.
T
h
e 
Jo
u
rn
al
 o
f 
E
xp
er
im
en
ta
l 
M
ed
ic
in
e
Sangster et al.1017
and MLN cells 7 d after infection (unpublished data), iden-
tified only B cells of donor origin in chimeric mice recon-
stituted with CD40/ and MT BM. In addition, allo-
typic differences between donor (Ighb) and recipient (Igha)
mice, and the application of allotype-specific assays to ana-
lyze AFC responses in the MLN, ensured that the mea-
sured Ab responses were by donor (CD40/) B cells.
Analysis of splenic CD4 T cells by IFN- ELISPOT assay
established that influenza infection activated virus-specific
CD4 T cells in the chimeras with CD40/ B cells (un-
published data).
Influenza-specific AFC responses in the MLN on day 7
after infection were compared for the chimeric mice,
CD40/ mice, and B6 mice (Fig. 7). Virus-specific IgM
and IgG responses in the chimeras with CD40/ B cells
were substantially decreased compared with those in B6
mice and the control chimeras, and were generally not sig-
nificantly stronger than in CD40/ mice. In striking con-
trast, the chimeras with CD40/ B cells produced a vigor-
ous, virus-specific IgA response that far exceeded the
response in CD40/ mice, and was not significantly differ-
ent from the IgA responses in B6 mice and the control chi-
meras. Thus, the early, virus-specific IgA response is distinct
from the IgM and IgG responses and can be driven by CD4
T cell activation in the absence of CD40 signaling to B cells.
Comparative Analysis of the Virus-specific and Total Ab Re-
sponse to Influenza Infection: Signaling Requirements for Non-
specific B Cell Activation. The B cell response to many vi-
rus infections includes the production of large quantities of
Abs that are not specific for virus-encoded molecules (31).
Studies of a range of DNA and RNA virus models indicate
that nonspecific Ab induction is CD4 T cell dependent
and reflects polyclonal B cell activation (21, 32, 33), but the
molecular mechanisms remain unclear. The construction of
chimeric mice in which CD4 T cells can be activated, but
B cells are MHC II/ or CD40/, provided an opportu-
nity to evaluate the ability of activated CD4 T cells to
drive nonvirus-specific Ab production in the absence of
key cognate T–B interactions.
A massive increase in total IgG2a AFC numbers dwarfed
the virus-specific IgG2a response in WT control chimeras
and B6 mice (Fig. 8 A), indicating that influenza virus, like
many other viruses (31), elicits a vigorous nonvirus-specific
IgG2a response. The increase in total IgG2a AFCs in chi-
meric mice with either MHC II/ or CD40/ B cells
was substantially smaller than in WT mice, and no greater
than the response in MHC II/ or CD40/ mice. Thus,Figure 7. CD40-deficient B cells generate a vigorous, influenza-specific
IgA response in the MLN of chimeric mice. Mice were infected i.n. with
influenza virus and sampled after 7 d. Virus-specific AFC frequencies are
shown for CD40/ mice, B6 mice, and the radiation BM chimeras
CD40/ plus MT → B6-Igha and B6 plus MT → B6-Igha described in
the legend to Fig. 3. The samples (from 6–15 individual mice per group)
were analyzed as described in the legend to Fig. 4. B6 compared with
CD40/: P  0.0001 for IgM, IgG1, IgG2a, or IgG2b; P  0.0005 for
IgA or IgG3. CD40/ compared with CD40/ plus MT → B6-Igha:
P  0.001 for IgA; P  0.005 for IgG2a; P  0.01 for IgG2b. B6 compared
with CD40/ plus MT → B6-Igha: P  0.005 for IgM, IgG1, IgG2a,
IgG2b, or IgG3.
Figure 8. The influenza-specific IgG2a response, but not the IgA response,
includes a nonspecific component. Mice were infected i.n. with influenza
virus and sampled after 7 d. Virus-specific and total IgG2a AFCs (A) and
IgA AFCs (B) in the MLN are shown for MHC II–deficient mice (I-Ab/),
CD40-deficient mice (CD40/), B6 mice, and the radiation BM chimeras
I-Ab plus MT → B6-Igha, CD40/ plus MT → B6-Igha, and B6
plus MT → B6-Igha described in the legend to Fig. 3. Virus-specific
AFC numbers were determined as described in the legend to Fig. 4. Total
AFC numbers were determined in parallel with the analyses presented in
Figs. 4 and 7 using ELISPOT assays specific for IgG2ab or IgAb. The mean
 SE is shown for 6–20 individual mice per group. Baseline levels of
AFCs in the MLN of uninfected mice were negligible for I-Ab/ plus
MT → B6-Igha chimeras and 18  7.4 (IgG2a) and 18  7.1 (IgA) for
B6 mice and B6 plus MT → B6-Igha control chimeras. B6 compared
with I-Ab/ or CD40/, and B6 plus MT → B6-Igha compared with
I-Ab/ plus MT → B6-Igha or CD40/ plus MT → B6-Igha: P 
0.0005 for total IgG2a AFCs.
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activated CD4 T cells are insufficient to drive nonvirus-
specific IgG2a production in the absence of signaling to B
cells via MHC II or CD40.
In contrast, the total IgA AFC number closely approxi-
mated the virus-specific IgA AFC number in each mouse
sampled (Fig. 8 B), demonstrating that the virus-specific
IgA response does not have a nonspecific component. This
analysis reinforces the finding that activated CD4 T cells
drive extensive virus-specific IgA production by MHC II/
or CD40/ B cells and emphasizes the distinction be-
tween the IgA and IgG responses. In addition, a form of
compartmentalization between the IgA and IgG2a re-
sponses is suggested by the observation that substantial
numbers of nonvirus-specific B cells were activated to
produce IgG2a, but IgA production was confined to virus-
specific B cells.
Discussion
This study demonstrates that a CD4 T cell–dependent,
virus-neutralizing IgA response to influenza infection can
be generated in the absence of cognate interactions involv-
ing MHC II or CD40 on the B cell. Therefore, the mech-
anism for the production of this IgA does not fit with the
generally accepted model for the delivery of CD4 T cell
help in T-dependent B cell responses. In this model, key
elements of cognate T–B collaboration are TCR recogni-
tion of an antigenic peptide–MHC II complex on the B
cell, and the interaction of CD40L on the T cell with B
cell–expressed CD40 (3, 15, 29, 34). In contrast to our
findings for IgA, our observations regarding the T-depen-
dent induction of influenza-specific IgM and IgG are con-
sistent with this model.
In chimeric mice with activated, virus-specific CD4 T
cells, substantial virus-specific IgA was produced by MHC
II/ or CD40/ B cells (Figs. 4–7). Thus, the IgA re-
sponse was driven by nonspecific or bystander help because
Ag-specific recognition of B cells by T cells was not a pre-
requisite. A strong IgA response by CD40/ B cells in the
chimeras indicates that bystander help was not the result of
CD40L up-regulation on activated CD4 T cells. How-
ever, we have not determined whether B cells that are
doubly deficient in MHC II and CD40 expression are able
to produce virus-specific IgA in the chimera model, and
there might be some redundancy in the signaling require-
ments for IgA responses. Our studies raise the possibility
that other contact-mediated interactions between T and B
cells are of particular importance in the influenza-specific
IgA response. Indeed, multiple molecules expressed by B
cells transmit B cell activation and differentiation signals
following the engagement of ligands on T cells (3).
We demonstrated influenza-specific IgA with virus-neu-
tralizing activity in concentrated washings from the nasal
passages of WT mice and also chimeric mice in which the
responding B cells were MHC II/ (Fig. 6 B). Thus, by-
stander help is sufficient to drive the rapid appearance of vi-
rus-neutralizing IgA in the nasal passages, a location where
it can have a direct antiviral effect (27, 28). Our data dem-
onstrate a correlation between a strong, virus-specific IgA
response in the MLN and the presence of virus-specific IgA
in the nasal passages, suggesting that IgA effector cells gen-
erated in the MLN migrate to the lamina propria of the re-
spiratory tract. Generation of an early, virus-neutralizing
IgA response in the MLN, as indicated by our studies, is
supported by the finding that hybridomas derived from the
MLN of mice as early as 6 d after i.n. influenza infection
secreted IgA that neutralized the homologous virus strain
(Coleclough, C., personal communication).
The role of the germinal center (GC) reaction in the
generation of the early IgA response to influenza infection
is unclear. GCs are considered critical for the affinity matu-
ration of Ab responses, a process likely to be required if an-
tiviral Abs are to have neutralizing capability. Our findings
indicate that influenza-neutralizing IgA was generated early
in the response by MHC II/ B cells, and this may also
have been the case for CD40/ B cells. However, addi-
tional studies are required to determine whether this IgA is
indeed the product of affinity maturation in responding B
cells. It is generally believed that T–B interactions involv-
ing MHC II and CD40 are required for effective GC de-
velopment (35). However, there is evidence that at least in
some systems, optimal CD4 T cell activation can promote
GC formation and function, even in the absence of signal-
ing via CD40 (36). It also remains a possibility that the
early, influenza-specific IgA response is independent of
conventional GC reactions. Sealy et al. (37) recently found
that i.n. influenza infection of WT mice induced IgA AFCs
in the MLN before GCs could be identified.
Our analysis of total AFC numbers in parallel with mea-
surements of the virus-specific AFC response (Fig. 8) clearly
showed that nonvirus-specific IgG2a production, like the vi-
rus-specific IgG2a response, was dependent on cognate T–B
interactions involving B cell–expressed MHC II or CD40.
Unexpectedly, these studies demonstrated yet another dis-
tinctive feature of the IgA response, namely, that it did not
include a nonvirus-specific component. This was the case
even though the magnitude of the virus-specific IgA re-
sponse often greatly exceeded the magnitude of the virus-
specific IgG2a response in the MLN. It is surprising that
large numbers of nonvirus-specific B cells can be activated to
produce IgG2a, and yet none of these cells are induced to
switch to IgA expression in a LN microenvironment that
supports a strong, virus-specific IgA response. These findings
further emphasize distinctions between the IgA and IgG re-
sponses and strongly suggest a form of compartmentalization
that limits IgA switch signals only to virus-specific B cells. It
remains to be determined whether a similar situation exists
in the gastrointestinal tract that, unlike the respiratory tract,
is a site of chronic immune stimulation and IgA induction
that could potentially promote nonspecific IgA production
in association with Ag-specific responses.
The cellular interactions and specific signals that are re-
quired for rapid IgA responses in the respiratory tract re-
main unclear. There is evidence that TGF-1 is a key fac-
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tor inducing B cells to switch to IgA expression (38, 39).
However, it is likely that optimal IgA responses depend on
a complex pattern of B cell stimulation involving TGF-1
and other cytokines in combination with cross-linking of
surface Ig receptors and other mitogenic signals (40). Our
observation that IgA switch signals were only delivered to
virus-specific B cells even though there was extensive,
nonspecific B cell activation in the MLN of WT mice, in-
dicates a requirement for close cellular interactions. Full
development of the early, virus-specific IgA response was
dependent on CD4 T cells, but surprisingly, classical Ag-
specific T–B collaboration was not required. This raises the
possibility that CD4 T cells may not provide the key IgA
switch signal, but simply drive the proliferation and differ-
entiation of IgA-expressing B cells. There is evidence that
DCs may present native Ag directly to B cells and promote
isotype switching, including switching to IgA expression
(12, 13, 41). Recent in vitro studies by Litinskiy et al. (41)
demonstrate that BLyS and APRIL, up-regulated on DCs
by stimuli such as IFN-, bind to receptors on B cells and
induce class switch recombination to C and C in the
presence of IL-10 or TGF-. However, Ab secretion re-
quires additional B cell stimulation via B cell receptor
cross-linking, and is enhanced by IL-15 or IL-2. A role for
DC–B cell interactions in the generation of IgA responses
in the respiratory tract is not yet established, but it might be
relevant that influenza virus–infected DCs remain viable
and express virion surface glycoproteins on the cell mem-
brane for a prolonged period (42). Such an array of viral
glycoproteins may provide the basis for cognate DC inter-
actions with virus-specific B cells as well as deliver a potent
stimulatory signal to the B cells via B cell receptor cross-
linking. This idea is consistent with evidence that the early
IgA response in the MLN after influenza infection is de-
pendent on virus replication (8) and directed exclusively
against virion envelope glycoproteins (37).
It is clear that at least the IgM and IgG2a component of
the specific response to influenza infection is produced by
follicular B-2 cells, and not by cells of the B-1 lineage (43).
However, a role for B-1 cells in the influenza-specific IgA
response has not been ruled out. Indeed, B-1 cells contrib-
ute significantly to secreted IgA in the intestine and gener-
ate specific, T cell–independent IgA responses to intestinal
bacteria (44). Furthermore, we show that at least a compo-
nent of the early, virus-specific IgA response to influenza
infection is mechanistically distinct from the IgM and IgG
responses, and this could be taken to indicate IgA produc-
tion by a distinct B cell lineage with different activation re-
quirements, such as B-1 cells (45). Nevertheless, we believe
that the following points argue against a large role for B-1
cells in the influenza-specific IgA response. (a) The early,
influenza-specific IgA response was CD4 T cell depen-
dent, whereas IgA production by B-1 cells, including Ag-
specific IgA responses, does not require T cell help (44). (b)
A vigorous, influenza-specific IgA response developed
in CBA/CaHN-Btkxid/J mice (unpublished data), even
though this strain is deficient in B-1 cells (46). (c) B-1 cells
are largely undetectable in the LNs of normal mice (47). (d)
The chimeric mice used in our studies were constructed by
transferring adult BM cells to irradiated recipients, a process
that preferentially reconstitutes B-2 rather than B-1 cells
(48 and unpublished data).
In our studies, irradiated recipient mice were reconsti-
tuted with BM from MT mice in combination with BM
from another donor strain. Recently, Macpherson et al.
(49) demonstrated IgA production in MT mice with the
B6 genetic background, raising the possibility that the
transplanted MT BM contributed B cells capable of pro-
ducing IgA in response to influenza infection. However,
comprehensive control experiments (Fig. 2) clearly estab-
lished that Ab responses in chimeric mice were not gener-
ated by cells derived from MT BM. Moreover, the anti-
influenza IgA response characterized in our studies is
substantially dependent on CD4 T cells, whereas the pro-
duction of IgA by MT mice is T cell independent and ap-
parently represents a response to intestinal bacteria (49).
Our demonstration that a CD4 T cell–dependent IgA
response to influenza infection can be generated in the ab-
sence of signaling to B cells via MHC II establishes that the
process is driven by non-Ag–specific bystander help. It fol-
lows that the necessary T cell help might be provided not
only by virus-specific CD4 T cells that are responding to
infection, but also by activated CD4 T cells that are spe-
cific for heterologous Ags. Indeed, an activated CD4 T
cell population might be a feature of the lung in nonspe-
cific pathogen-free hosts because the airways are continu-
ously exposed to environmental Ags, and activated, virus-
specific CD4 T cells persist in lung tissues for long periods
after infection (50). Influenza-specific memory CD4 T
cells (51) may also provide bystander help to drive rapid,
virus-specific IgA production by naive B cells, a potentially
important mechanism because polarized Th1 memory
CD4 T cells (52) may tend to promote switching to IgG
isotypes if they engaged B cells in Ag-specific cognate in-
teractions. In this way, memory CD4 T cells may con-
tribute to the so-called heterosubtypic immunity that is
broadly protective against multiple influenza A subtypes
(28, 53).
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